A Bacterial Protein's Role in Gum Health and Disease
A T.fosythia-derived protease inhibitor in periodontal health and disease
This research explores how a protein from a common mouth bacterium might help control the gum inflammation seen in periodontal disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10885972 on NIH RePORTER |
What this research studies
Chronic inflammation in gum disease, or periodontitis, happens when there's too much enzyme activity damaging the gums. Certain bacteria in the mouth, like Porphyromonas gingivalis and Tannerella forsythia, release enzymes that kick off and spread this inflammation. Our own immune system also releases enzymes that contribute to tissue damage. Interestingly, Tannerella forsythia produces a special protein called miropin, which can block these harmful enzymes from both bacteria and our own bodies. This project aims to understand how miropin works and if it can protect against gum disease.
Who could benefit from this research
Good fit: This foundational research does not involve direct patient participation but aims to benefit individuals suffering from chronic periodontitis in the future.
Not a fit: Patients without periodontal disease or those whose condition is not driven by excessive protease activity may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat gum disease by controlling harmful enzymes.
How similar studies have performed: While the role of proteases in periodontitis is well-established, the specific mechanism and therapeutic potential of miropin as an inhibitor are being explored in this novel approach.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Potempa, Jan S — University of Louisville
- Study coordinator: Potempa, Jan S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.